MedTrace Logo

Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome

NCT02399059 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2015-03-26

No results posted yet for this study

Summary

Antibiotic lavage reduces bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome.

Conditions

  • Colorectal Tumors

Interventions

PROCEDURE

Antibiotic lavage

Peritoneal irrigation with gentamycin-clindamycin solution

PROCEDURE

Normal saline lavage

Peritoneal irrigation with normal saline

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Principal Investigators

  • Jaime Ruiz-Tovar, MD, PhD · Hospital Rey Juan Carlos

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399059 on ClinicalTrials.gov